Newsletters published on March 3, 2022
In this activity, two experts discuss asparaginase therapy in pediatric ALL, including administration considerations and how to manage asparaginase hypersensitivity and silent inactivation.

For more information on acute lymphoblastic leukemia, click here.
Newsletters published on March 2, 2022
In this newsletter, three experts discuss biosimilars in hematology/oncology practice and what their economic impact may be.

For more information on biosimilars, click here.

Results 1 - 2 of 2